244 related articles for article (PubMed ID: 17014629)
1. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
[TBL] [Abstract][Full Text] [Related]
5. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
[TBL] [Abstract][Full Text] [Related]
6. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
[TBL] [Abstract][Full Text] [Related]
8. Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis.
Pucci N; Novembre E; Lombardi E; Massai C; Bernardini R; Caputo R; Campa L; de Libero C; Vierucci A
Pediatrics; 2005 Jan; 115(1):e86-91. PubMed ID: 15629970
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
11. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
[TBL] [Abstract][Full Text] [Related]
12. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
[TBL] [Abstract][Full Text] [Related]
14. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
Kiliç A; Gürler B
Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
[TBL] [Abstract][Full Text] [Related]
15. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
[TBL] [Abstract][Full Text] [Related]
18. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
Sahin A; Bozkurt B; Irkec M
Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
[TBL] [Abstract][Full Text] [Related]
20. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
Oray M; Toker E
Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
